An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive benefit, in a phase 2/3 clinical trial led by researchers at Washington University School…
Neuroscientists have established in recent decades the idea that some of each day's experiences are converted by the brain into permanent memories during sleep...
Study populationThe JPSC-AD Study was a multisite, population-based, prospective, cohort study of dementia involving eight sites in Japan with a pre-specified protocol and standardized...